Dna molecules encoding ctenocephalides felis glutamate gated chloride channels
CA 2299618 A1 · Owner: Cohen, Charles J. · Inventors: Cohen, Charles J.; Paress, Philip S.; Warmke, Jeffrey W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
To date, L-glutamate-gated chloride (GluC1) channels have been observed only in invertebrate organisms. Modulators of this channel (either agonists or antagonists) will interfere with neurotransmission. For example agents such , as avermectins activate the GluCl causing paralysis due to blocking of , neurotransmitter release resulting in death of the organism. Because GluCl channels are invertebrate specific, they are excellent targets for the discovery of novel insecticides, anthelminths and parasiticides that will display a marked safety profile because of the lack of mechanism based toxicity in vertebrate organisms. The present specification discloses isolation of a cDNA clone …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 10, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 10, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 10, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.